It’s not often this happens, which is why we think it’s important enough to tell you about.

But even one of the scientists who holds a patent on a new heart drug has concerns about its safety and effectiveness. He has joined us in writing a letter to the FDA urging the agency to stop its review of the drug, called prasugrel.